glofitamab,epcoritamab,axicabtagene ciloleucel,tisagenlecleucel,Lisocabtagene Maraleucel
Roche,genmab,abbvie,gilead,novartis,bms
['lymsm']
dr. sehn: starting to see long term durable cr with bites, and toxicity is much less with bites. and her "favorite slide" about complexity of car manufacturing and delivery ("look at the happy patient on the right getting off the shelf therapy outpatient") #lymsm #17icml 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈